LeMaitre Vascular, Inc. Priced Public Offering Of Common Shares

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., May 30, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced the pricing of an underwritten public offering of 1,430,000 shares of its common stock at a price to the public of $7.00 per share. In addition, LeMaitre Vascular has granted the underwriters a 30-day option to purchase up to an additional 214,500 shares of common stock solely to cover over-allotments, if any. The offering is expected to close on or about June 4, 2014, subject to customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Back to news